Pharmacodynamic
6
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects
Pharmacodynamic Evaluation of Intranasal Nalmefene
Population Pharmacokinetics/Pharmacodynamics of Carbapenems in Febrile Neutropenia Patients
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers